US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist
  • 3.4300
  • -0.4900-12.50%
Close Jan 10 16:00 ET
  • 3.4300
  • 0.00000.00%
Post 19:33 ET
50.60MMarket Cap1.01P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VYNE Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 100.000K --
-- 2024/Q4 -- / 140.000K --
-- 2024/Q3 121.000K / 110.000K --
-- 2024/Q2 198.000K / 110.000K --
-- 2024/Q1 98.000K / 100.000K --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 140.000K--
--2024/Q3121.000K / 110.000K--
--2024/Q2198.000K / 110.000K--
--2024/Q198.000K / 100.000K--

Unlock Free Earnings Estimates

VYNE Therapeutics Earnings Reports

  • VYNE Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 05:14

  • VYNE Therapeutics | 8-K: VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 7, 2024 21:08

  • VYNE Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 15, 2024 04:53

  • VYNE Therapeutics | 8-K: VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 14, 2024 20:09

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 1, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data